1PGY1 Pharmacy Resident, Veterans Affairs Nebraska-Western Iowa Health Care System, Lincoln, Nebraska.
2PGY1 Pharmacy Resident, Veterans Affairs Nebraska-Western Iowa Health Care System, Lincoln, Nebraska.
Sr Care Pharm. 2021 Jan 1;36(1):42-48. doi: 10.4140/TCP.n.2021.42.
The purpose of this quality improvement project was to increase pharmacist involvement in the outpatient hospice transition process to improve care of veterans, prevent medication errors, and to ensure medications are provided to the patient via the appropriate pharmacy. This project began with implementation of a pilot process for the pharmacist to complete medication reconciliation for each patient admitted to non-Veterans Affairs (VA) hospice care from the Omaha VA Medical Center. The second step of this project was completion of a retrospective chart review of the interventions made. Statistical analysis was completed via descriptive statistics. A total of 21 patients were eligible for this study. The mean age was 78 years. The average total number of medications per veteran before and after medication reconciliation for VA meds were 13 and 4 and for non-VA meds were 4 and 6, respectively. The average total cost savings for one fill of all medications changed to non-VA was estimated to be $40.08. The pharmacist noted on average 12.6 medication discrepancies during medication reconciliation per veteran. Just less than half of the clinical recommendations made by the pharmacist were accepted by the providers. All veterans admitted to non-VA hospice care had at least one medication discrepancy noted by the pharmacist during medication reconciliation. A majority of the veterans had at least one VA medication changed to non-VA since hospice was now prescribing and providing. The cost savings on average appear to outweigh the time spent on medication reconciliation by the pharmacist.
本质量改进项目的目的是增加药剂师参与门诊临终关怀过渡过程,以改善退伍军人的护理,预防用药错误,并确保通过适当的药房向患者提供药物。该项目始于为药剂师实施一项试点流程,以便为从奥马哈退伍军人事务医疗中心转入非退伍军人事务(VA)临终关怀护理的每位患者完成药物治疗重整。该项目的第二步是对所采取的干预措施进行回顾性图表审查。通过描述性统计完成了统计分析。共有 21 名患者符合本研究条件。平均年龄为 78 岁。退伍军人接受 VA 药物治疗重整前后,VA 药物的平均用药数量分别为 13 种和 4 种,而非 VA 药物的平均用药数量分别为 4 种和 6 种。所有药物改用非 VA 药物的单次配药的平均总成本节省估计为 40.08 美元。药剂师在每位退伍军人的药物治疗重整中平均记录了 12.6 个药物差异。药剂师提出的临床建议中,只有不到一半被医疗服务提供者接受。所有转入非 VA 临终关怀护理的退伍军人在药物治疗重整期间都至少有一个药物差异被药剂师记录下来。由于临终关怀现在开始开处方和提供药物,大多数退伍军人至少有一种 VA 药物被改为非 VA 药物。药剂师在药物治疗重整上花费的时间似乎超过了节省的成本。